SOL Global Investments
(OTC: SOLCF)
Healthcare | Drug Manufacturers - Specialty & Generic
1.63
0.03
1.87%
Stock Price |
June 17, 2019, 3:48 p.m.
Bid:
1.6
Ask:
1.65
Prev. Close:
1.6
52 Week Low:
52 Week High:
PE Ratio:
0.0
Dividend Yield:
0.0%
Company Summary
Scythian Biosciences Corp is a pre-clinical research and development company. It is engaged in the process of development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. In addition, it is also involved in the development of cannabinoid and non-cannabinoid based pharmaceutical products for treatment of gastro-inflammatory disease. Geographically, the activities are carried out through the region of Canada.
Read more Read less
